On Friday, April 26th, the OncoSET Symposium will provide healthcare professionals with state of the art information related to new advances in precision medicine looking beyond mutations in cancer treatment and care. The program will focus on improving the detection of fusions and their therapeutic vulnerabilities, enhancing future incorporation of multiomics assays into management decisions and discussing established and future molecular imaging targets. Participants will learn strategies for translating advances in precision medicine to their clinical practice.
Event Details
Keynote Speaker
David Hong
MD Anderson Cancer Center
NTRK Fusion in Solid Tumors
Conference Fees
| Lurie Cancer Center Affiliate Rates Affiliates include Northwestern University, Northwestern Medicine, Lurie Children's, Shirley Ryan AbilityLab, and Jesse Brown VA. |
||
|---|---|---|
| Student, Fellow or Resident | Complimentary | |
| Nurse or Allied Health Professional | $25 | |
| Research Staff | $25 | |
| Faculty and/or Physician | $50 | |
| General Rates | ||
| Student, Fellow or Resident | Complimentary | |
| Nurse or Allied Health Professional | $50 | |
| Research Staff | $50 | |
| Faculty and/or Physician | $75 | |
| Industry Representative | $250 | |
All participants must register in advance to receive connection information.
Conference Chair
Northwestern University
Accreditation Information
Target Audience
This activity is intended for healthcare professionals involved in the treatment and care of patients with advanced or refractory cancers for whom precision medicine can help guide treatment choices. This includes medical, surgical, and radiation oncologists, pathologists, radiologists, other translational-oriented laboratory scientists, nurses, pharmacists, genetic counselors, and physician assistants.
Objectives
- Improve the detection of fusions and their therapeutic vulnerabilities
- Enhance future incorporation of multiomics assays into management decisions
- Discuss established and future molecular imaging targets
Accreditation Statement
The Northwestern University Feinberg School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
The Northwestern University Feinberg School of Medicine designates this live activity for a maximum of 4.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Board of Surgery Continuous Certification Program
Successful completion of this CME activity enables the learner to earn credit toward the CME requirement of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit. ABS CME credits will be submitted to the boards within 3 months of the conclusion of the activity.
Other Credits
The American Academy of Nurse Practitioners and the American Nurses Credentialing Center accept AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.
Faculty Disclosure
Current guidelines state that participants in CME activities should be made aware of any affiliation of financial interest that may affect the speaker's presentation. Each speaker has been requested to complete a faculty disclosure form. The names of faculty members declaring a relationship or who will be discussing off-label usage will be indicated in the course syllabus.
Additional Information
For additional information about the event, please contact us at cancer@northwestern.edu or 312-503-7809.
See also the OncoSET Precision Medicine webpage.